Suppr超能文献

乳腺钼靶筛查:澳大利亚维多利亚州一项基于人群的项目中的成本测算

Mammographic screening: measurement of the cost in a population based programme in Victoria, Australia.

作者信息

Hurley S F, Livingston P M, Thane N, Quang L

机构信息

Cancer Epidemiology Centre, Anti-Cancer Council of Victoria, Australia.

出版信息

J Epidemiol Community Health. 1994 Aug;48(4):391-9. doi: 10.1136/jech.48.4.391.

Abstract

STUDY OBJECTIVES

To estimate the cost per woman participating in a mammographic screening programme, and to describe methods for measuring costs.

DESIGN

Expenditure, resource usage, and throughput were monitored over a 12 month period. Unit costs for each phase of the screening process were estimated and linked with the probabilities of each screening outcome to obtain the cost per woman screened and the cost per breast cancer detected.

SETTING

A pilot, population based Australian programme offering free two-view mammographic screening.

PARTICIPANTS

A total of 5986 women aged 50-69 years who lived in the target area, were listed on the electoral roll, had no previous breast cancer, and attended the programme.

RESULTS

Unit costs for recruitment, screening, and recall mammography were $17.54, $60.04, and $175.54, respectively. The costs of clinical assessment for women with subsequent clear, benign, malignant (palpable), and malignant (impalpable) diagnoses were $173.71, $527.29, $436.62, and $567.22, respectively. The cost per woman screened was $117.70, and the cost per breast cancer detected was $11,550.

CONCLUSIONS

The cost per woman screened is a key variable in assessment of the cost effectiveness of mammographic screening, and is likely to vary between health care settings. Its measurement is justified if decisions about health care services are to be based on cost effectiveness criteria.

摘要

研究目的

估算参与乳腺钼靶筛查项目的每位女性的成本,并描述成本测量方法。

设计

在12个月期间监测支出、资源使用和工作量。估算筛查过程各阶段的单位成本,并将其与每种筛查结果的概率相关联,以得出每位接受筛查女性的成本以及每例检测出的乳腺癌的成本。

背景

一项基于澳大利亚人群的试点项目,提供免费的双视角乳腺钼靶筛查。

参与者

共有5986名年龄在50 - 69岁之间、居住在目标区域、登记在选民名单上、既往无乳腺癌且参加了该项目的女性。

结果

招募、筛查和召回钼靶检查的单位成本分别为17.54美元、60.04美元和175.54美元。后续诊断为明确、良性、恶性(可触及)和恶性(不可触及)的女性的临床评估成本分别为173.71美元、527.29美元、436.62美元和567.22美元。每位接受筛查女性的成本为117.70美元,每例检测出的乳腺癌的成本为11550美元。

结论

每位接受筛查女性的成本是评估乳腺钼靶筛查成本效益的关键变量,且可能因医疗保健环境而异。如果要根据成本效益标准做出关于医疗保健服务的决策,那么对其进行测量是合理的。

相似文献

4
A cost utility analysis of mammography screening in Australia.
Soc Sci Med. 1992 May;34(9):993-1004. doi: 10.1016/0277-9536(92)90130-i.
7
Cost-effectiveness of breast cancer screening in women on dialysis.透析女性乳腺癌筛查的成本效益
Am J Kidney Dis. 2008 Nov;52(5):916-29. doi: 10.1053/j.ajkd.2008.06.015. Epub 2008 Sep 11.
8
A mammographic screening pilot project in Victoria 1988-1990. The Essendon Breast X-ray Program Collaborative Group.
Med J Aust. 1992 Nov 16;157(10):670-3. doi: 10.5694/j.1326-5377.1992.tb137433.x.

本文引用的文献

1
Breast cancer screening and health service costs.乳腺癌筛查与医疗服务成本。
J Health Econ. 1982 Aug;1(2):185-207. doi: 10.1016/0167-6296(82)90014-5.
2
The distinction between cost and charges.成本与收费之间的区别。
Ann Intern Med. 1982 Jan;96(1):102-9. doi: 10.7326/0003-4819-96-1-102.
5
Screening for breast cancer.乳腺癌筛查
Ann Intern Med. 1989 Sep 1;111(5):389-99. doi: 10.7326/0003-4819-111-5-389.
6
The cost-effectiveness of breast cancer screening.乳腺癌筛查的成本效益
Int J Cancer. 1989 Jun 15;43(6):1055-60. doi: 10.1002/ijc.2910430617.
7
Screening: the need for a population register.筛查:建立人口登记册的必要性。
Med J Aust. 1990 Sep 17;153(6):310-1. doi: 10.5694/j.1326-5377.1990.tb136935.x.
8
On the Oregon trail: rationing health care.在俄勒冈小道上:医疗保健配给
BMJ. 1991 Jan 5;302(6767):1-2. doi: 10.1136/bmj.302.6767.1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验